- Sabra Health Care press release (NASDAQ:SBRA): Q1 FFO of $0.32 misses by $0.01.
- Revenue of $166.75M (+3.4% Y/Y) beats by $2.94M.
-
2024 GUIDANCE
Sabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):
- Net Income: $0.53 - $0.57
- FFO: $1.33 - $1.37 vs. consensus of $1.37
- Normalized FFO: $1.34 - $1.38
- AFFO: $1.38 - $1.42
- Normalized AFFO: $1.39 - $1.43
Sabra Health Care reports mixed Q1 results; reaffirms FY24 outlook
Recommended For You
Comments
More Trending News
About SBRA Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SBRA | 14.87 | 0.88% |
| Sabra Health Care REIT, Inc. | Post. 14.80 | -0.47% |
| CTRE | 24.82 | -0.24% |
| CareTrust REIT, Inc. | Post. 24.82 | 0.00% |
| NHI | 65.64 | -0.02% |
| National Health Investors, Inc. | Post. 65.64 | 0.00% |
| MPW | 4.46 | 4.21% |
| Medical Properties Trust, Inc. | Post. 4.45 | -0.22% |
| AHR | 13.78 | -1.50% |
| American Healthcare REIT, Inc. | Post. 13.78 | 0.00% |
Trending Analysis
Trending News
1
2
3
4
5